Denmark Faces Nokia Moment on $100 Billion Stock
February 01, 2013
Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech... Read More
from CNBC.com News
Denmark Faces Nokia Moment on $100 Billion Stock
February 01, 2013
Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech... Read More
from CNBC.com News
Media Digest (2/1/2013) Reuters, WSJ, FT, Bloomberg
February 01, 2013
DailyFinance.com : PMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell Inc. (NASDAQ: DELL) may be only week away. (Reuters) The cost of beef has squeezed... Read More
from DailyFinance.com
AstraZeneca (AZN) Opens Lower After Reports Q4 Results
January 31, 2013
AstraZeneca slumps in weak U.K. market
January 31, 2013
Shares of drug maker AstraZeneca PLC and oil firm Royal Dutch Shell PLC lead U.K. stocks lower on Thursday after lackluster earnings reports, while banks drop after facing large payouts to... Read More
from MarketWatch
Europe stocks drop after mixed earnings, FOMC
January 31, 2013
European stock markets are broadly lower in choppy trade on Thursday, after a mixed bag of earnings from the region’s companies and downbeat comments from the U.S. Federal Reserve. Read More
from MarketWatch
European Shares Called Lower; US Growth Concern Weighs
January 31, 2013
European shares are expected to open lower on Thursday after news that U.S. gross domestic product (GDP) unexpectedly contracted in the fourth quarter pushed Wall Street shares down. Read More
from CNBC.com News
Trading Radar for 0131: Dow (DOW), MasterCard (MA), UPS (UPS), Viacom (VIAB), Under Armour (UA) Report
January 30, 2013
Best Move of the Year So Far? Playing the Flu
January 29, 2013
Amid all the hyper-bullishness about the stock market this year, the effectiveness of the swine flu play may be getting lost. Yes, one of the most effective strategies has been betting on shares of... Read More
from CNBC.com News
category
Pharmaceuticals
,
Unassigned
from Trefis
Earnings Buzz: What to Watch in the Week Ahead
January 25, 2013
Earnings season is shifting into high gear in the final week of January, with six Dow Jones components, and more than a fifth of the S&P 500 companies reporting. With the Dow rallying to its highest... Read More
from CNBC.com News
Flu’s Pain Is All Gain for These Companies
January 24, 2013
Plavix Patent Cliff Will Impact Bristol-Myers’ Earnings
January 23, 2013
category
Pharmaceuticals
,
Unassigned
from Trefis
Europe stocks inch higher; Admiral jumps
January 21, 2013
European stock markets move cautiously higher on Monday, taking a cue from a strong U.S. close last week on the back of encouraging news about the debt ceiling and strong corporate earnings. Read More
from MarketWatch
AstraZeneca (NYSE: AZN) Might Be Interested in Shire (SHPG)
January 17, 2013
AstraZeneca neuroscience unit inks deal with Vanderbilt University
January 14, 2013
Johnson & Johnson Diabetes Drug Endorsed by Review Panel
January 11, 2013
ChartWatch: Two Speculative Flu Stocks
January 10, 2013
Johnson & Johnson Diabetes Medicine Faces Big Test
January 08, 2013
Shanghai Fosun Pharma continued to execute on its growth-by-acquisition strategy by paying $93 million for a 78% stake in Hunan Dongting Pharmaceutical Co., a company that makes CNS and hemostatic... Read More
from ChinaBio® Today
An Overview Of Bristol-Myers’ Business And $34 Price Estimate
January 03, 2013
category
Pharmaceuticals
from Trefis
16 Really Cheap International Dividend Achiever You Need To Know
December 31, 2012
category
Mining
from Trefis
A Look Back At The Year In Pharmaceuticals (PFE, SNY, NVO, AZN)
December 28, 2012
Week in Review: WuXi PharmaTech and PRA Form Clinical CRO JV
December 22, 2012
WuXi PharmaTech is forming a JV with PRA, a US-based clinical-stage CRO, that will offer Phase I-IV clinical trial services in China; ShangPharma agreed to a go-private offer from its Founder and TPG... Read More
from ChinaBio® Today
AstraZeneca and Fudan Univ. to Collaborate on Cardiovascular Disease
December 19, 2012
AstraZeneca will collaborate with Fudan University to discover the mechanism behind leonurine, a TCM product derived from Herba Leonuri that is used to treat heart disease, ischemic stroke and... Read More
from ChinaBio® Today
Abbott: Potential Upside As Humira Competitors Face Setbacks
December 18, 2012
category
Pharmaceuticals
from Trefis
Astrazeneca Says Got Updated Guidelines on Stemi
December 17, 2012
AstraZeneca (AZN) Enters In-Lincensing Deal for Progenics' (PGNX) Clostridium Difficile Program
December 17, 2012
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here